The aim is to bring the Nordic countries a step closer to a collaborative model for personalized medicine that utilizes the medical and technological advances to the fullest, in an ethically robust, legally compliant and societally responsible manner.
The conference is a collaboration between the Norwegian Cancer Genomics Consortium, Oslo Cancer Cluster, The Norwegian Biotechnology Advisory Board, Oslo University Hospital, Nordic Network for Early Cancer Trials, The University Hospital of North Norway, Nordic Trial Alliance and NRI Networks.
The conference is supported by NordForsk and UiO:Life Science. ??